Immunotherapy in the Management of Lung Cancer

Immunotherapy in the Management of Lung Cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.

Detalhes bibliográficos
Autor principal:	Tasnim, Humayra
Outros Autores:	khan, Tanisha Tabassum Sayka
Formato:	Thesis
Idioma:	en_US
Publicado em:	Brac University 2022
Assuntos:	Lung cancer Immunotherapy Cytokines Checkpoint inhibitors Adoptive cell therapy Vaccines Cancer > Treatment Cancer > Immunotherapy
Acesso em linha:	http://hdl.handle.net/10361/17515

Registos relacionados

Current practice and approaches of immunotherapy in Cancer treatment
Por: Khondokar, Faiza
Publicado em: (2022)

A review on targeted therapies for lung cancer
Por: Ashraf, Anushey
Publicado em: (2023)

Immunotherapy in the treatment of renal cancer
Por: Shimu, Sumaya
Publicado em: (2022)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
Por: Ratu, Tabassum
Publicado em: (2024)

Immunotherapeutic approaches to treat cancer: Prospects and challenges
Por: Fred, Namanda Rogers
Publicado em: (2021)

A review paper on Nanotechnology based strategies in the treatment of cancer
Por: Rahman, Samia
Publicado em: (2022)

CAR-T cell Therapy in B-cell Lymphoma
Por: Faruk, Asef
Publicado em: (2020)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
Por: Flora, Sanzida Alam
Publicado em: (2024)

Dendritic cell vaccine for the treatment of cancer
Por: Haque, Tanzila
Publicado em: (2023)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
Por: Abir, Shifaty Nur
Publicado em: (2024)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
Por: Bristy, Israt Zerin
Publicado em: (2021)

Role of toll-like receptors in cancer immunotherapy– a review
Por: Khan, Rezia Nowrin
Publicado em: (2021)

Stem cell in cancer disease cure vs cause
Por: Chowdhury, Marisha Mansur
Publicado em: (2023)

RIPK pathway, as a potential target, for cancer treatment - a review
Por: Jahan, Nusrat
Publicado em: (2024)

Molecules associated with the development of lung cancer
Por: Rahman, Adree, et al.
Publicado em: (2023)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
Por: Rahman, Sanjida
Publicado em: (2024)

Potential of liposomes for the treatment of lung cancer- a review
Por: Mim, Shanzida
Publicado em: (2023)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
Por: Rahman, Tasnim
Publicado em: (2024)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
Por: Tania, Umme
Publicado em: (2023)

A review on recent advances in drugs for lung cancer treatment
Por: Noor, Fouzia
Publicado em: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
Por: Jeba, Joynob
Publicado em: (2017)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
Por: Razna, Amrin Islam
Publicado em: (2019)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
Por: Meem, Manila
Publicado em: (2023)

A review on potential of PARP inhibitors in the treatment of prostate cancer
Por: Islam, Saidul
Publicado em: (2022)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
Por: Pial, Sazia Afrin
Publicado em: (2018)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
Por: Paul, Pulock
Publicado em: (2024)

Stem cells as therapeutic carrier in cancer treatment
Por: Anika, Mysha Yeasmin
Publicado em: (2022)

Recent advances in Cancer treatment targeting autophagy and future aspects
Por: Emon, Kamrul Hasan
Publicado em: (2022)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
Por: Shabnam, Musharrat
Publicado em: (2018)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
Por: Zangmo, Thinley
Publicado em: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
Por: Hoque, Ismoth Ara
Publicado em: (2024)

A comprehensive review on drug repurposing in cancer treatment
Por: Sarkar, Onusree
Publicado em: (2024)

Lung cancer detection and classification using machine learning
Por: Arefin, Mahbubul, et al.
Publicado em: (2023)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
Por: Nandy, Aditi
Publicado em: (2022)

Targeted therapeutic options in the treatment of Breast Cancer
Por: Alam, Kazi Tasnuva
Publicado em: (2022)

Molecular biology of cancer : mechanisms, targets, and therapeutics /
Por: Pecorino, Lauren
Publicado em: (2012)

Statistics and informatics in molecular cancer research

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
Por: Khan, Muidul Hasan
Publicado em: (2024)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
Por: Kamal, Tasnova
Publicado em: (2019)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
Por: Hasan, Amit
Publicado em: (2024)